Pathology Service Joint Venture

{
  "awards": [
    {
      "id": "020539-2025-1",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-147363",
          "name": "SYNLAB"
        }
      ]
    }
  ],
  "bids": {
    "statistics": [
      {
        "id": "13",
        "measure": "bids",
        "relatedLot": "1",
        "value": 1
      },
      {
        "id": "14",
        "measure": "electronicBids",
        "relatedLot": "1",
        "value": 1
      }
    ]
  },
  "buyer": {
    "id": "GB-FTS-40530",
    "name": "The Christie NHS Foundation Trust"
  },
  "contracts": [
    {
      "awardID": "020539-2025-1",
      "dateSigned": "2025-05-12T00:00:00+01:00",
      "id": "020539-2025-1",
      "status": "active",
      "value": {
        "amount": 200000000.0,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-05-12T14:59:13+01:00",
  "description": "The proposed contract is to be let for an initial term of 180 months. There is also an option to extend the Contract by up to a further 60 months following the initial term.",
  "id": "020539-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-03a281",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Manchester",
        "postalCode": "M20 4BX",
        "region": "UKD3",
        "streetAddress": "Wilmslow Road"
      },
      "contactPoint": {
        "email": "diane.sinclair@nhs.net",
        "name": "Diane Sinclair",
        "telephone": "+44 7748624560"
      },
      "details": {
        "buyerProfile": "https://www.christie.nhs.uk/",
        "classifications": [
          {
            "description": "Body governed by public law",
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "https://www.christie.nhs.uk/"
      },
      "id": "GB-FTS-40530",
      "identifier": {
        "legalName": "The Christie NHS Foundation Trust"
      },
      "name": "The Christie NHS Foundation Trust",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "SE1 1NA",
        "region": "UKI",
        "streetAddress": "Francis House, 9 King\u0027s Head Yard, London."
      },
      "contactPoint": {
        "email": "amy.davenport@synlab.co.uk"
      },
      "details": {
        "scale": "sme",
        "url": "http://www.synlab.co.uk"
      },
      "id": "GB-FTS-147363",
      "identifier": {
        "id": "03216065",
        "legalName": "SYNLAB"
      },
      "name": "SYNLAB",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "streetAddress": "The Strand"
      },
      "details": {
        "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
      },
      "id": "GB-FTS-1661",
      "identifier": {
        "legalName": "The High Court"
      },
      "name": "The High Court",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Pathology services",
      "id": "85111800",
      "scheme": "CPV"
    },
    "coveredBy": [
      "GPA"
    ],
    "description": "The Trust has worked with a commercial partner in a joint venture (JV) arrangement to deliver a comprehensive pathology service for the last 10 years. Building on this knowledge and experience, the Trust was looking for a new partner that matches its ambitions.\u003cbr/\u003eThe initial term of the pathology service JVwill be for a period of fifteen (15) years with an option to extend by up to five (5) years.\u003cbr/\u003eThe Trust was looking for a partner that will;\u003cbr/\u003e\u2022 Provide an exceptional, high-quality service that meets the specialist needs of a\u003cbr/\u003ecomprehensive cancer centre;\u003cbr/\u003e\u2022 Provide investment for the provision of world class infrastructure;\u003cbr/\u003e\u2022 Embrace the exciting opportunities presented with the co-location of a world leading\u003cbr/\u003eoncology research centre; and\u003cbr/\u003e\u2022 Provide expert guidance along with the creativity and drive to deliver a modern, thriving,\u003cbr/\u003etruly exceptional pathology service for patients.",
    "id": "ocds-h6vhtk-03a281",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Hospital and related services",
            "id": "85110000",
            "scheme": "CPV"
          },
          {
            "description": "Blood analysis services",
            "id": "85111810",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKD3"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "13",
              "name": "Clinical / Operational",
              "type": "quality"
            },
            {
              "description": "5",
              "name": "Quality and Safety",
              "type": "quality"
            },
            {
              "description": "4.8",
              "name": "Implementation",
              "type": "quality"
            },
            {
              "description": "4.8",
              "name": "Future-proofing",
              "type": "quality"
            },
            {
              "description": "4.2",
              "name": "Research \u0026 Innovation",
              "type": "quality"
            },
            {
              "description": "8",
              "name": "Workforce",
              "type": "quality"
            },
            {
              "description": "8",
              "name": "I\u0026MT",
              "type": "quality"
            },
            {
              "description": "7.2",
              "name": "Strategy, Risk \u0026 Governance",
              "type": "quality"
            },
            {
              "description": "10",
              "name": "Social Value",
              "type": "quality"
            },
            {
              "description": "5",
              "name": "Legal",
              "type": "quality"
            },
            {
              "description": "30",
              "type": "price"
            }
          ]
        },
        "description": "The current pathology service provides routine and specialist pathology services with c100 dedicated staff on The Christie Hospital site. The service includes translational biomarker development and supports the Trust\u2019s ambitious Research and Innovation (R\u0026I) programme and clinical trials portfolio.\u003cbr/\u003e\u003cbr/\u003eDemand for testing is increasing year on year reflecting the Trust\u2019s oncology case load.  The Trust sought a JV pathology partner who is able to deliver the Trust\u2019s strategic ambitions, including accommodation of projected testing growth demand and flexible options for the development of facilities, estate, technology, and changes in clinical pathways.\u003cbr/\u003e\u003cbr/\u003eVision\u003cbr/\u003eTo provide a world leading comprehensive pathology service that supports timely and highquality\u003cbr/\u003edelivery of patient care - regionally and nationally - and develops an internationally recognised workforce who, with academic and industry partners, deliver a pioneering\u003cbr/\u003eprogramme of research and innovation.\u003cbr/\u003e\u003cbr/\u003ePrinciples/Objectives\u003cbr/\u003eThe Future Pathology Service should reflect the following principles/objectives:\u003cbr/\u003e\u003cbr/\u003e\u2022 Safe, effective, and responsive to the diversity of patient and clinical needs and offers the specialist and integrated pathology services needed to support a regional tertiary cancer centre.\u003cbr/\u003e\u2022 Delivery of a sustainable future pathology workforce\u003cbr/\u003e\u2022 alignment with the Trust\u2019s Vision and Values and the objectives of Greater Manchester Cancer.\u003cbr/\u003e\u2022 Commitment to working as part of Greater Manchester ICS in the delivery of the Core20PLUS5 programme to support the reduction of health inequalities at both national and system level.\u003cbr/\u003e\u2022 Enabled by a strong digital infrastructure and capability. Adopting digital opportunity and technology advances to deliver more efficient and scalable pathology services.\u003cbr/\u003e\u2022 A service model that considers The Trust\u2019s local, regional national and international partnerships, including engagement with the Greater Manchester Pathology Network to\u003cbr/\u003eexplore opportunities to support system requirements.\u003cbr/\u003e\u2022 Delivered through a partnership that has a strategy for profitable growth through expanding test repertoire and customer base.\u003cbr/\u003e\u2022 Builds upon the Trust\u2019s reputation as an international leader in research and innovation, which is further strengthened by being a partner in the Manchester Cancer Research Centre\u003cbr/\u003e(MCRC) and Health Innovation Manchester.\u003cbr/\u003e\u2022 A service with capital investment to provide best in class facilities.\u003cbr/\u003e\u2022 A service that has education at its core.\u003cbr/\u003e\u003cbr/\u003eThe Future Operating Model for Pathology must include:\u003cbr/\u003e\u003cbr/\u003e\u2022 An end-to-end comprehensive pathology service\u003cbr/\u003e\u2022 Blood sciences including haematology, blood transfusion, clinical biochemistry and immunoassay\u003cbr/\u003e\u2022 On-site essential services laboratory to support time critical and pathway critical services\u003cbr/\u003e\u2022 Histopathology (including immunohistochemistry and receptor analysis)\u003cbr/\u003e\u2022 Stem Cell Laboratory\u003cbr/\u003e\u2022 Point-of-Care Testing\u003cbr/\u003e\u2022 A future-proof design with activity growth in service expectation factored in \u2013 including expansion of on-site and off-site facilities to meet projected demand;\u003cbr/\u003e\u2022 An agile approach that can respond to evolving technology and operational requirements and provide improvements to the Trust Pathology Estate;\u003cbr/\u003e\u2022 Training, Development and Education, Research and Innovation\u003cbr/\u003e\u2022 Positive workplace culture\u003cbr/\u003e\u2022 IT infrastructure and digital enablement (including Digital Histopathology)\u003cbr/\u003e\u2022 Best in class equipment and instrumentation",
        "hasOptions": false,
        "id": "1",
        "status": "cancelled"
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "selective",
    "procurementMethodDetails": "Competitive dialogue",
    "status": "complete",
    "title": "Pathology Service Joint Venture"
  }
}